Skip to content

The clinical accurate localization of Salvianolic Acids for Injection in the treatment of ischemic cerebrovascular disease inacute stage - a multi-center, single-arm, open clinical protocol.

The clinical accurate localization of Salvianolic Acids for Injection in the treatment of ischemic cerebrovascular disease inacute stage - a multi-center, single-arm, open clinical protocol.

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005489
Enrollment
Unknown
Registered
2022-01-03
Start date
2022-01-03
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute Ischemic stroke

Interventions

Sponsors

Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Ischemic stroke onset in the preceding 72 hours 2.National Institutes of Health Stroke Scale 6 to 20(including the boundary value) 3.Males and females aged 18 years or older 4.First onset or historical stroke without sequela and mRS score <= 1 5.Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Cranial imaging confirmed brain tumor, encephalitis, brain abscess and other diseases with similar symptoms, or confirmed hemorrhagic cerebral infarction, epidural hematoma, intracranial hematoma, ventricular hemorrhage, subarachnoid hemorrhage. 2. Severe disturbance of consciousness(NIHSS Ia >=2)3.Allergic to the drug ingredients used in the study. 4. Patients with severe primary diseases of heart, liver, kidney, blood and endocrine system. 5. Pregnant and lactating women. 6. Drug or alcohol abuser. 7. Mentally ill. 8. Participants who are participating in or have participated in other clinical trials within a month. 9. The researchers did not consider the selected subjects appropriate.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale;

Secondary

MeasureTime frame
MMSE;Metabonomics;Barthel index;The incidence of MACCE;NIHSS;The incidence of apoplexy-related complications;

Countries

China

Contacts

Public ContactXu Qiang
tcmxuqiang@hotmail.com+86 022-60637959

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026